SCHEMBL10272857

SCHEMBL10272857

CCOc1cc(NS(C)(=O)=O)ccc1-c1cnccc1OC

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 19/20 0.77
SLC22A12 Q96S37 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526757 0.90 CYP17A1 (0.81) CYP17A1SLC22A12
SCHEMBL526698 0.88 CYP17A1 (0.77) CYP17A1SLC22A12
SCHEMBL526951 0.87 CYP17A1 (0.76) CYP17A1
SCHEMBL527076 0.87 CYP17A1 (1.00) CYP17A1
SCHEMBL10272858 0.86 CYP17A1 (0.78) CYP17A1
SCHEMBL527370 0.85 CYP17A1 (0.76) CYP17A1
SCHEMBL527307 0.83 CYP17A1 (0.73) CYP17A1SLC22A12
SCHEMBL527311 0.83 CYP17A1 (0.75) CYP17A1SLC22A12
SCHEMBL526423 0.82 CYP17A1 (0.92) CYP17A1
SCHEMBL526883 0.82 CYP17A1 (0.69) CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012015723-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-02 WO disclosed